Corleen M. Roche - 08 Jun 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Financial Officer
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
08 Jun 2023
Net transactions value
$0
Form type
4
Filing time
12 Jun 2023, 16:58:46 UTC
Previous filing
21 Jun 2022
Next filing
26 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock Option (Right to Buy) Award $0 +58,000 $0.000000 58,000 08 Jun 2023 Common Stock 58,000 $4.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-forty-eighth (1/48th) of the shares subject to such options shall vest monthly over forty-eight months after the grant date.